WST monthly performance report
Explore WST's monthly returns, drawdown, and seasonality trends — updated every month.
WST monthly report
—
Key takeaways
- West Pharmaceutical Services (WST) closed November 2026 at $411.30, down 0.32% for the month and +50.19% over the trailing 12 months.
- Year-to-date, WST is +49.49%, outperforming the S&P 500 which has returned +11.03% YTD.
- The stock is trading +28.50% versus its 200-day moving average ($320.07), a bullish technical signal.
- Over the past three years, WST has underperformed the S&P 500 by −51.45%, with a relative strength index reading of 70.7.
- Win rate over the trailing 39 months stands at 53.8% — 21 positive months versus 18 negative months.
West Pharmaceutical Services ended November 2026 at $411.30, posting a monthly return of −0.32%. The S&P 500 returned +0.19% over the same window, leaving relative performance at −0.51%.
The current quarter stands at +10.93% (Q4 2026 (QTD)), while medium-term trend remains constructive: price is +28.50% versus the 200-day moving average ($320.07).
Year-to-date, WST is +49.49% against SPY +11.03%, a gap of +38.46%. The stock is currently −6.15% below its 52-week high, with maximum 3-year drawdown at −53.90%.
| Period | WST | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −0.38% | −0.35% | −0.02% |
| 1 Week | +4.80% | +3.29% | +1.50% |
| 1 Month | −0.32% | +0.19% | −0.51% |
| 3 Months | +17.71% | −2.48% | +20.19% |
| 6 Months | +36.01% | +2.00% | +34.02% |
| YTD | +49.49% | +11.03% | +38.46% |
| 12 Months | +50.19% | +10.79% | +39.40% |
| 3 Years | +20.39% | +71.83% | −51.45% |
| Rank | Month | Return |
|---|---|---|
| #1 | Apr 2026 | +18.73% |
| #2 | Oct 2026 | +11.29% |
| #3 | Jun 2026 | +11.21% |
| #4 | Mar 2024 | +10.42% |
| #5 | Nov 2023 | +10.20% |
| Rank | Month | Return |
|---|---|---|
| #1 | Feb 2025 | −31.97% |
| #2 | Jan 2026 | −16.00% |
| #3 | Oct 2023 | −15.17% |
| #4 | Apr 2024 | −9.66% |
| #5 | Sep 2023 | −7.79% |
| Quarter | Return |
|---|---|
| Q3 2025 | +19.89% |
| Q4 2025 | +4.88% |
| Q1 2026 | −8.90% |
| Q2 2026 | +43.23% |
| Q3 2026 | +3.28% |
| Q4 2026 (QTD) | +10.93% |
| Year | Return |
|---|---|
| 2023 | +49.62% |
| 2024 | −6.97% |
| 2025 | −16.00% |
| 2026 | +49.49% |
| Metric | Value |
|---|---|
| 52-Week High | $438.26 (2026-10-29) |
| 52-Week Low | $223.83 (2026-01-30) |
| Current Price | $411.30 |
| 200-Day Moving Average | $320.07 |
| Price vs 200DMA | +28.50% |
| 3-Year Maximum Drawdown | −53.90% (2025-04-08) |
| Current Drawdown from 52W High | −6.15% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 70.7 |
| 3-Year Excess Return vs S&P 500 | −51.45% |
| RS Peak | 107.9 (Feb 2024) |
| RS Trough | 42.5 (Feb 2025) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was WST's return for this report period?
WST returned −0.32% in the latest monthly window ending 2026-11-12.
Has WST outperformed SPY year to date?
YTD WST: +49.49% vs SPY: +11.03%.
What is WST's 12-month return?
+50.19% over the trailing 12 months.
Is WST above or below its 200-day moving average?
Price is +28.50% versus 200DMA ($320.07).
What is the maximum drawdown in the 3-year window?
−53.90% on 2025-04-08.